STRATEGIES FOR EQUITABLE PHARMACOGENOMIC-GUIDED WARFARIN DOSING AMONG EUROPEAN AND AFRICAN AMERICAN INDIVIDUALS IN A CLINICAL POPULATION

The blood thinner warfarin has a narrow therapeutic range and high inter- and intra-patient variability in therapeutic doses. Several studies have shown that pharmacogenomic variants help predict stable warfarin dosing. However, retrospective and randomized controlled trials that employ dosing algor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Pac Symp Biocomput
Autores principales: WILEY, LAURA K., VANHOUTEN, JACOB P., SAMUELS, DAVID C., ALDRICH, MELINDA C., RODEN, DAN M., PETERSON, JOSH F., DENNY, JOSHUA C.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5389380/
https://ncbi.nlm.nih.gov/pubmed/27897005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares